NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 5

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

compared with

New Version 6

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: For CTRPMICRO-11, revised based on ClinicalTrials Final Rule - Data Elements Requirements.xlsx.

...

Field Label

Description/Instructions

Studies a U.S. FDA-regulated Drug Product*

Include Page
Regulatory Drug field - Include 20170414
Regulatory Drug field - Include 20170414

Studies a U.S. FDA-regulated Device Product*

Include Page
Regulatory Device field - Include 20170414
Regulatory Device field - Include 20170414

Unapproved/Uncleared Device*

Include Page
Regulatory Unapproved Uncleared field - Include 20170414
Regulatory Unapproved Uncleared field - Include 20170414

Post Prior to U.S. FDA Approval or Clearance

Include Page
Regulatory Post Prior field - Include 20170414
Regulatory Post Prior field - Include 20170414

Pediatric Post-market Surveillance

Include Page
Regulatory Pediatric field - Include 20170414
Regulatory Pediatric field - Include 20170414

Product Exported from the U.S.

Include Page
Regulatory Exported field - Include 20170414
Regulatory Exported field - Include 20170414

FDA Regulated Intervention Indicator*

Indicate whether the trial is regulated by the FDA by selecting Yes or No.

Note

You must select YES in the FDA Regulated Intervention Indicator field if the trial includes an IND or IDE.
If the trial is interventional and you indicated that it is regulated by the FDA, the Regulatory Information section displays fields for Section 801. You are required to complete these fields.

Section 801 Indicator*

For interventional trials, indicate whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801 by selecting Yes or No.

Note

If you indicated that the trial is applicable under Section 801, the Delayed Posting Indicator field becomes available and defaults to No. This field is read-only. You may request a change in its value by submitting a request to the CTRO at ncictro@mail.nih.gov.

Delayed Posting Indicator*

This indicator becomes available only when you indicate that the trial is applicable under Section 801. Only the CTRO can modify this indicator’s value:

  • A No value indicates that any devices in the trial have already been approved or cleared by the US FDA, and so there is no need to delay posting of trial information information on ClinicalTrials.gov.
  • A Yes value indicates that the release of trial information on ClinicalTrials.gov is being delayed until after an interventional device has been approved or cleared.

To change this indicator’s value, submit a request to the CTRO at ncictro@mail.nih.gov.

Data Monitoring Committee Appointed Indicator

Optionally, indicate whether a data monitoring committee has been appointed for this trial by selecting Yes or No.

Info

This information is required for compliance with the Public Law 110-85 of the Food and Drug Administration Amendment Act of 2007. If you are unsure about how to classify a trial, or what information to provide, contact the FDA's regulatory affairs office.